In neuroblastoma, BMI-1 is shown to be essential for neuroblastoma tumorigenesis in vitro and in vivo, cooperating with MYCN via inhibition of MYCN driven apoptosis and downregulation of p53 expression (Cui et al., 2007; Huang et al., 2011b). Here, BMI1 is linked to neuroblastoma.